Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

KTTA

+ Watchlist+ Portfolio

Pasithea Therapeutics Corp.

Regulated industryPhysical productsDevelopment stageTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$0.43
52-Week Range
$0.28 – $2.06
Market Cap
$18.78M
P/E (TTM)
—
EPS (TTM)
-1.59
Dividend Yield
0.00%
Advanced Metrics
Price/Book
0.39
PEG Ratio
—
Return on Equity
-88.78%
Return on Assets
-49.18%
Gross Margin
0.00%
Operating Margin
0.00%
Profit Margin
0.00%
Current Ratio
15.67
Debt/Equity
—
Total Debt
$0.00
Free Cash Flow
$-13.24M
Revenue Growth
—
Earnings Growth
—
Enterprise Value
$-22.44M

Market Snapshot

About

Pasithea Therapeutics is a biotechnology company focused on developing treatments for psychiatric and neurological disorders. The company's pipeline includes therapies targeting depression, addiction, pain management, and other central nervous system conditions. Pasithea leverages novel mechanisms of action and drug delivery technologies to address significant unmet medical needs in mental health.